3 ms·
this is not a cure, but mAb therapies are a very promising approach for a therapy, particularly because the basic idea already is known to work well, there's be
by hprotagonist 6y ago
this is not a cure, but mAb therapies are a very promising approach for a therapy, particularly because the basic idea already is known to work well, there's been some encouraging preliminary work, and it looks like a good target.
Sorrento are by no means the only people working on this: it's by far the most promising approach we have to give us some breathing room to get a vaccine out.
more mAb reading:
- https://blogs.sciencemag.org/pipeline/archives/2020/05/15/good-news-on-the-human-immune-response-to-the-coronavirus https://blogs.sciencemag.org/pipeline/archives/2020/05/15/go...
- https://blogs.sciencemag.org/pipeline/archives/2020/04/27/monoclonal-antibodies-for-the-coronavirus https://blogs.sciencemag.org/pipeline/archives/2020/04/27/mo...
- https://blogs.sciencemag.org/pipeline/archives/2020/05/06/details-of-a-new-anti-coronovirus-neutralizing-antibody https://blogs.sciencemag.org/pipeline/archives/2020/05/06/de...
- lbeltrame 6y agoAren't mAb therapies very expensive, though? My experience in oncology tells me that some mAb courses (bevacizumab, for example) have costs that go through the roof.